Skip to main content
Vitamin D deficiency is associated with lumbar disc disease and LBP in postmenopausal women; moresoe w/ very low vitamin D concentration < 10 ng/m

Dr. John Cush RheumNow

6 years 7 months ago
Vitamin D deficiency is associated with lumbar disc disease and LBP in postmenopausal women; moresoe w/ very low vitamin D concentration < 10 ng/mL - study of 232 postmenopausal women https://t.co/Kmu8nMOaf7
The Annals of Rheumatic Disease reports that interleukin- 27 (IL-37) may play an important role in the pathogenesis of gout, paving the way for future therapy with recombinant IL-37 in gouty arthritis. Activation of the inflammasome by monosodium urate crystals is thought to be paramount to the innate immune response that drives IL-1-mediated joint inflammation in gout.
U.S. FDA Accepts Regulatory Submission for Tanezumab, an NGF inhibitor, for the Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Ost

Dr. John Cush RheumNow

6 years 7 months ago
U.S. FDA Accepts Regulatory Submission for Tanezumab, an NGF inhibitor, for the Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis https://t.co/9NsESTnn4S
"He has all of the virtues I dislike and none of the vices I admire." -Winston Churchill

Dr. John Cush RheumNow

6 years 7 months ago
"He has all of the virtues I dislike and none of the vices I admire." -Winston Churchill
QD Clinic - Cases, insights and RNL info. Listen to the podcasts on iTunes or here https://t.co/V60JN2ZdYF

Dr. John Cush RheumNow

6 years 7 months ago
QD Clinic - Cases, insights and RNL info. Listen to the podcasts on iTunes or here https://t.co/V60JN2ZdYF
Dr Jack Cush Reviews the news and journal articles from the past week on RheumNow.com
Long term safety of Sarilumab reviewed. 2887 SAR pts on Combo and 471 on SAR mono Rx for up to 7.3 yrs (8188 PYs). SAEs 9.4 &amp; 6.7/100PY; SIE 3.7

Dr. John Cush RheumNow

6 years 7 months ago
Long term safety of Sarilumab reviewed. 2887 SAR pts on Combo and 471 on SAR mono Rx for up to 7.3 yrs (8188 PYs). SAEs 9.4 & 6.7/100PY; SIE 3.7 &, H zoster (0.5-0.6/100PY), GI perforations < 0.1/100PY & Cancer 0.7-.6. ANC <1000 in 13-15% https://t.co/YA2TKCdpGY
Study of metformin in NON-diabetics w/ inflammatory disease on Pred &gt;20/d shows metformin to to reduce pneumonia, serious infections, markers of c

Dr. John Cush RheumNow

6 years 7 months ago
Study of metformin in NON-diabetics w/ inflammatory disease on Pred >20/d shows metformin to to reduce pneumonia, serious infections, markers of carbohydrate/lipid,/liver & bone metabolism (vs PBO) but had no effect on truncal fat https://t.co/8RE2fJMkv9
RT @Janetbirdope: Prof Dinesh Khanna has an algorithm for SSc ILD. High CRP is a risk. HRCT is only low radiation so use for dx and prognos…

Janet Pope Janetbirdope

6 years 7 months ago
Prof Dinesh Khanna has an algorithm for SSc ILD. High CRP is a risk. HRCT is only low radiation so use for dx and prognosis #CRA2020 great lecture @RheumNow @earlyarthritis @sclerodermaUM https://t.co/VgltxqFKCo
RT @CCalabreseDO: Syphilis = The great imitator! Dx further muddled by periods of active and inactive disease. 2 main diagnostic algorithms…

Cassandra Calabrese CCalabreseDO

6 years 7 months ago
Syphilis = The great imitator! Dx further muddled by periods of active and inactive disease. 2 main diagnostic algorithms that rely on serology, and both have pitfalls! @LCalabreseDO @NEJM @HealioRheum https://t.co/PvIG8hX0Ht https://t.co/EFTBYhK8QF
RT @KDAO2011: Anyone else getting hysterical patients? They want to stop their biologic because they “know” they are going to get #COVID201…

k dao KDAO2011

6 years 7 months ago
Anyone else getting hysterical patients? They want to stop their biologic because they “know” they are going to get #COVID2019 . I tell them their risk of their disease flaring off med is 100% while their risk for the infection is <1%. What do you tell your patients? @RheumNow https://t.co/2I8kVlKLOC
Hospital for Special Surgery (HSS) announced the appointment of S. Louis Bridges, Jr., MD, PhD, as the new Physician-in-Chief and Chair of the Divisio

Dr. John Cush RheumNow

6 years 7 months ago
Hospital for Special Surgery (HSS) announced the appointment of S. Louis Bridges, Jr., MD, PhD, as the new Physician-in-Chief and Chair of the Division of Rheumatology, effective September 1, 2020. Dr. Bridges succeeds Mary K. Crow, MD https://t.co/TQ55jMOXHj
Fatigue is an important component of the disease experience in systemic lupus erythematosus (SLE), and can have a profound impact on patients' perception of well-being, Italian researchers reported.
×